发表论文

发表论文:
 

2020

  • An J, Hu YG, Chang K, Li C, Hou XL, Wang GL, Zhang XS, Liu B, Zhao YD and Zhang MZ*. ROS-Augmented and Tumor-Microenvironment Responsive Biodegradable Nanoplatform for Enhancing Chemo-Sonodynamic Therapy. Biomaterials. 2020. (IF=10.273)  
  • Yang C, Zhang MZ, Sung J, Wang L, Jung Y and Merlin D. Autologous Exosome Transfer: A New Personalized Treatment Concept to Prevent Colitis in a Murine Model. Journal of Crohn's and Colitis. 2020. (IF=7.827)
  • Fang B*, Guo P, Yang M, Yang C, Ma Y, Yan X, Jia Z, Gao W, Ahmad S, Xu CL and Zhang MZ*. A Novel Fluorescent Enhancing Platform Based on DNA-scaffolded Silver Nanoclusters for Potential Inflammatory Bowel Disease-associated MicroRNA Detection. Talanta. 2020. (IF=4.916)

  • Yang CH, Zhang MZ, Lama S, Wang LX and Merlin D. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis. Journal of Controlled Release. 2020. (IF=7.8)

2019

  • Zhang MZ*, Yang CH, Yan XJ, Sung JK, Garg P and Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics. 2019; 1900129. (Wiley new journal)
  • Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, Zhang MZ* and Merlin, D. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. Journal of Crohn's and Colitis. 2019. (IF=7.827)
  • Wang X, Zhang MZ, Flores SR, Woloshun RR, Yang C, Yin L, Xiang P, Xu X, Garrick MD, Vidyasagar S, Merlin D and Collins JF*. Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis. Molecular Therapy. 2019; 27(3):493-506. (IF=8.402)
  • Li C, Yang XQ, Zhang MZ, Song YY, Cheng K, An J, Zhang XS, Xuan Y, Liu B, Zhao YD. In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene-and Photothermal Therapy. Theranostics. 2018; 8(20):5662. (IF=8.063)
  •  Zhang MZ*, Xu CL, Wen LQ, Han MK, Xiao B, Zhou J and Merlin D. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research. 2016; 76(24), 7208-7218. (IF=8.378)
  • Zhang MZ*, Viennois E, Prasad M, Zhang YC, Wang LX, Zhang Z and Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101:321-340. (IF=10.273)
  • Zhang MZ, Yu Y, Yu RN, Wan M, Zhang RY and Zhao YD*. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide. Small. 2013; 9:4183-4193. (IF=10.856)  
  •  Zhang MZ*, Xiao B, Wang H, Han MK, Zhang Z, Viennois E and Merlin D. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy. 2016; 24(10):1783-96. (IF=8.402)
  • Zhang MZ*, Xu CL, Liu DD, Han MK, Wang LX and Merlin D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. Journal of Crohn’s and Colitis. 2018; 12(2): 217-229. (IF=7.827)
  • Zhang MZ*, Viennois E, Xu CL and Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016; e1134415.
  • Zhang MZ*, Collins JF and Merlin D. Do Ginger-derived nanoparticles present an attractive treatment strategy for inflammatory bowel disease? Nanomedicine. 2016; 3035-3037. (IF=4.717)
  • Zhang MZ*, Wang XY, Han MK, Collins JF and Merlin D. Oral administration of ginger-derived nano-lipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. 2017; 12(16), 1927-1943. (IF=4.717)
  • Zhang MZ, Yu RN, Chen J, Ma ZY and Zhao YD*. Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells. Nanotechnology. 2012; 23:485104. (IF=3.399)
  • Zhang MZ, Li C, Fang BY, Yao MH, Ren QQ, Zhang L and Zhao YD*. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting. Nanotechnology. 2014; 25:255102. (IF=3.399)
  •  Zhang MZ* and Merlin D. Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases. 2018; 24(7):1401-1415. (IF=4.005)